Australia is closely watching the arrival of retatrutide, a innovative dual GIP and GLP-1 receptor therapy, representing a significant advance in weight loss . Early research findings have demonstrated https://bike-giant-talon-2045349.plpwiki.com/8021281/emerging_medication_in_australia_a_new_hope_for_obesity_management